Tel:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@anticorps-enligne.fr

Virus-like Particles

A Virus-Like Particle (VLP) is a biological nanoparticle which consists of the protective protein shell of a virus. VLPs are a specific class of viral subunit vaccines that mimics the overall structure of virus particles without the infectious genetic material. VLPs don't contain the viral genetic material and so are non-infectious and safe to use as they cannot replicate.

VLPs are highly immunogenic due to high density display of epitopes, the capacity to present multiple proteins to the immune system and their size (typically around 40 nm, influenza VLP however 80–120 nm) which seems to be the optimal for uptake by dendritic cells. VLPs are particularly beneficial for immunizing against antigens that are present in low abundance or have weak immunogenicity. Additionally, they enable the soluble expression of multi-transmembrane proteins in their natural configuration.

Advantages of VLPs

  • Mammalian cell expression system expression, closer to the real structure and conformation
  • Strong immunogenicity
  • Biotinylation can be introduced at specific sites
  • Proven biological activity
  • Design different VLP frameworks for different antigens

Expression of VLPs

VLPs are derived from the outer capsid protein of a virus and are tiny nanoparticles formed by the automatic assembly of one or more capsid proteins. VLPs do not contain viral infectious genomes, so they are relatively safe during production operations. antibodies-online offers a series of biotinylated, non-biotinylated, and fluorescently-labeled VLP-displayed antigens. They are suitable for SPR, ELISA, CAR-T positive rate detection, and other experimental scenarios to flexibly meet customer needs. Discover our portfolio down below or get in touch for custom VLP solutions.

Therapeutic Agents and Vaccines

Virus-like particles (VLPs) are a promising option for delivering genes or other therapeutic agents. In vitro studies have demonstrated their effectiveness in selectively targeting cancer cells. Researchers believe that VLPs may accumulate in tumor sites due to the enhanced permeability and retention effect, making them a valuable tool for drug delivery and tumor imaging.

Moreover, VLPs can serve as effective vaccines. These particles display viral surface proteins with high-density repetitive patterns that present conformational viral epitopes, inducing robust T cell and B cell immune responses. VLPs have a small radius that allows for sufficient drainage into lymph nodes. As they are unable to replicate, they offer a safer alternative to attenuated viruses.

36 Résultats:

Origine: Humain Hôte: HEK-293 Cells VLP > 95 % as determined by HPLC ELISA, Func, Imm, SPR Active
N° du produit ABIN7448160
$1,250.00
Plus shipping costs $45.00
100 μg
Destination: Etats-Unis
Envoi sous 3 à 5 jours ouvrables
CLDN6 Origine: Humain Hôte: HEK-293 Cells VLP > 95 % as determined by HPLC. ELISA, Func, Imm, SPR Active
N° du produit ABIN7448162
$1,452.46
Plus shipping costs $45.00
100 μg
Destination: Etats-Unis
Envoi sous 3 à 5 jours ouvrables
CLDN6 Origine: Cynomolgus Hôte: HEK-293 Cells VLP > 95 % as determined by HPLC ELISA, Func, Imm, SPR Active
N° du produit ABIN7448159
$1,856.31
Plus shipping costs $45.00
100 μg
Destination: Etats-Unis
Envoi sous 3 à 5 jours ouvrables
ADORA2A Origine: Humain Hôte: HEK-293 Cells VLP > 95 % as determined by HPLC ELISA, Func, Imm, SPR Active
N° du produit ABIN7448150
$1,452.46
Plus shipping costs $45.00
100 μg
Destination: Etats-Unis
Envoi sous 11 à 13 jours ouvrables
GPRC5D Origine: Cynomolgus Hôte: HEK-293 Cells VLP > 95 % as determined by HPLC ELISA, Func, Imm, SPR Active
N° du produit ABIN7448167
$1,452.46
Plus shipping costs $45.00
100 μg
Destination: Etats-Unis
Envoi sous 11 à 13 jours ouvrables
GPRC5D Origine: Humain Hôte: HEK-293 Cells VLP > 95 % as determined by HPLC ELISA, Func, Imm, SPR Active
N° du produit ABIN7448169
$1,452.46
Plus shipping costs $45.00
100 μg
Destination: Etats-Unis
Envoi sous 3 à 5 jours ouvrables
SSTR2 Origine: Humain Hôte: HEK-293 Cells VLP > 95 % as determined by HPLC ELISA, Func, Imm, SPR Active
N° du produit ABIN7448172
$1,452.46
Plus shipping costs $45.00
100 μg
Destination: Etats-Unis
Envoi sous 11 à 13 jours ouvrables
GPRC5D Origine: Souris Hôte: HEK-293 Cells VLP > 95 % as determined by HPLC ELISA, Func, Imm, SPR Active
N° du produit ABIN7448171
$1,653.85
Plus shipping costs $45.00
100 μg
Destination: Etats-Unis
Envoi sous 11 à 13 jours ouvrables
Origine: Humain Hôte: HEK-293 Cells VLP > 95 % as determined by HPLC ELISA, Func, Imm, SPR Active
N° du produit ABIN7448161
$1,856.31
Plus shipping costs $45.00
100 μL
Destination: Etats-Unis
Envoi sous 3 à 5 jours ouvrables
CLDN6 Origine: Souris Hôte: HEK-293 Cells VLP > 95 % as determined by HPLC ELISA, Func, Imm, SPR Active
N° du produit ABIN7448164
$1,856.31
Plus shipping costs $45.00
100 μg
Destination: Etats-Unis
Envoi sous 3 à 5 jours ouvrables
  • Type Protein
    • Protein
  • Target
    • GPRC5D
    • Claudin 6 (CLDN6)
    • Claudin 18.2
    • CD20
    • CD24
    • CCR2
    • Glypican 3 (GPC3)
    • SSTR2
    • Adenosine A2a Receptor (ADORA2A)
    • Adenosine A2b Receptor (ADORA2B)
    • CXCR4 / CD184
    • CNR2
    • CCR5
    • CCR8
    • Envelop VLP Control
    • Hepatitis B Virus E Antigen (HBeAg)
    • TM4SF1
    • VLP Control
  • Application
    • ELISA
    • Functional Studies (Func)
    • Immunogen (Imm)
    • Surface Plasmon Resonance (SPR)
    • Lateral Flow (LF)
  • Réactivité
    • Human
    • Cynomolgus
    • Mouse
    • Hepatitis B Virus (HBV)
  • Images disponible
  • Hote
    • HEK-293 Cells
    • Escherichia coli (E. coli)
  • Conjugué
    • Inconjugué
    • Biotin
    • GFP tag
    • His tag
  • Type Proteine VLP
    • VLP
    • Recombinant
    • Native
    • Synthetic
  • Format
    • Lyophilized
    • Liquid
  • Activité biologique
    • Biologically Active
  • Supplier
    • antibodies-online
    • ACROBiosystems
Vous êtes ici:
Support technique